Otsuka Group News

Keyword search

Add search criteria

Search by company

Otsuka Holdings
Otsuka Pharmaceutical
Otsuka Pharmaceutical Factory
Taiho Pharmaceutical
Otsuka Warehouse
Otsuka Chemical
Otsuka Foods
Otsuka Medical Devices
Other

Search by category^*

Pharmaceuticals Business
Nutraceuticals Business
Consumer Products Business
Others
Products
R&D
Personnel
Corporate

* Business categories are based on the business segments described in the financial announcements.

Search by release date

-

Showing 101 results

Search by release date:: Jan, 2021 ～ Dec, 2021

December 21, 2021
Taiho Pharmaceutical

Taiho Pharmaceutical to Provide Matching Funds to Three Crowdfunded Projects Addressing Issues in the Field of Oncology　"The First Taiho Smile Support"
December 20, 2021
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory launches Actreen, an intermittent urological catheter
December 16, 2021
Otsuka Pharmaceutical

Otsuka and Rebirthel Sign Licensing Agreement for iPSC-derived CAR-T / TCR-T Production Technology
November 30, 2021
Taiho Pharmaceutical

Taiho Pharmaceutical Exercises Option for an Exclusive License to Arcus Biosciences’ Anti-TIGIT Program in Japan and Certain Territories in Asia
November 25, 2021
Taiho Pharmaceutical

Taiho and Meiji Announce the Launch of Bilanoa® OD Tablets 20mg, Anti-allergy Drug in Japan
November 24, 2021
Taiho Pharmaceutical

Taiho Pharmaceutical Launches BUP-4 LADY®, Japan's First OTC Medication Indicated for Urinary Urgency
November 18, 2021
Otsuka Pharmaceutical

Launch of tocoelle Supplement　- Gentle support for pre-menstrual fluctuations -
November 9, 2021
Otsuka Pharmaceutical

Announcement of Termination of Co-Development and Exclusive Marketing Agreements with Takara Bio for Oncolytic virus HF10 and CD19-Targeted CAR Gene Therapies
November 5, 2021
Otsuka Medical Devices

Reported latest data from landmark renal denervation clinical trials at TCT Annual Meeting
November 4, 2021
Otsuka Holdings

Otsuka Group Supports Recommendations of the Task Force on Climate-related Financial Disclosure (TCFD) -Joins TCFD Consortium-
November 4, 2021
Otsuka Foods

Otsuka Foods Launches Sinvino JAVA TEA Straight Red in Label-Free Bottles Packaging That Supports a Sustainable Society Available for Online Order Starting November 4
November 2, 2021
Otsuka Pharmaceutical

Otsuka Measurement Kit to Assist in Diagnosis and to Monitor Treatment Effectiveness for Acute Lymphoblastic Leukemia (ALL), to be Covered by Health Insurance in Japan
November 1, 2021
Otsuka Medical Devices

Otsuka Medical Devices Launches BioMimics 3D Vascular Stent System in Japan
October 29, 2021
Otsuka Pharmaceutical

Otsuka submits initial marketing authorization application to the European Medicines Agency for vadadustat for the treatment of adults with anemia associated with chronic kidney disease
October 15, 2021
Otsuka Medical Devices

Otsuka Medical Devices REQUIRE Trial Results Presented at Japan Society of Hypertension Annual Meeting
October 6, 2021
Otsuka Pharmaceutical

Otsuka Announces Approval in EU of Pediatric, 25 mg Dispersible-Tablet Formulation of Deltyba for Multidrug-Resistant Tuberculosis
October 4, 2021
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory concludes an exclusive marketing agreement in Japan with B. Braun Aesculap for Actreen, an intermittent urological catheter
September 30, 2021
Otsuka Pharmaceutical

Sumitomo Dainippon Pharma and Otsuka Announce a Worldwide Collaboration and License Agreement for Four Psychiatry and Neurology Compounds
September 30, 2021
Otsuka Foods

Otsuka Foods Launches “Uncooked Zero Meat Hamburgers for Commercial Use, ” A New Addition to the “Zero Meat” Series of Soy Meat Products for Commercial Use Animal Ingredient-Free Products That Use Plant-Derived Ingredients to Bring Out the Best Flavor and Taste ―All “Zero Meat” Products to Be Egg-Free―
September 27, 2021
Otsuka Pharmaceutical

Otsuka announces that Novartis Pharma’s ENTRESTO received a new indication for treatment of hypertension in Japan
September 27, 2021
Otsuka Pharmaceutical

Otsuka’s Moizerto Ointment Granted Approval in Japan as a Treatment for Atopic Dermatitis
September 21, 2021
Otsuka Foods

Otsuka Foods Revamps “Zero Meat” Series for Retail Sale:Now to Be Animal Ingredient-Free Products That Produce the Delicious Texture, Without Eggs Packaging Also to Be Changed with Phased Product Launch from Autumn
September 14, 2021
Taiho Pharmaceutical

Taiho Pharmaceutical Submits New Drug Application for its HSP90 Inhibitor Pimitespib (TAS-116) for GIST
September 6, 2021
Taiho Pharmaceutical

"Efil" Virus Removal/Antibacterial Spray Marks Its Debut Outside Japan, to Support Peace of Mind in Daily Life for People in Singapore"Turn your life around with Efil"
September 6, 2021
Taiho Pharmaceutical

Taiho Pharmaceutical Relocates Head Office
September 1, 2021
Taiho Pharmaceutical

Taiho Pharmaceutical's Drug Discovery Site in Tsukuba Fully Switches to Carbon-Neutral Electricity, and Newly Adopts Carbon Neutral City Gas Annual CO2 Emissions of the Tsukuba Area to Decline by Approximately 56%
September 1, 2021
Otsuka Holdings

100th Anniversary of Otsuka Group of Companies Looking Ahead to the Next 100 Years
August 31, 2021
Otsuka Foods

Otsuka Foods “Zero Meat” to Be Featured in Second New Menu Item at Denny’s, “Zero Meat Hamburger with Autumn Vegetables Power Salad” Starting September 7, 2021 at 137 Restaurants
August 30, 2021
Otsuka Pharmaceutical

Otsuka to Launch AJOVY Subcutaneous Injection 225 mg Syringe in Japan- Two dosing options for preventive treatment of migraine -
August 25, 2021
Otsuka Pharmaceutical

Busulfex Injection 60mg Approved in Japan for Once-daily Administration in Pediatric Patients